The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Sickle Cell Disease Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASCAT 2023 | Comparing adverse pregnancy outcomes in patients with SCD vs anemia
Lydia Pecker, MD, Johns Hopkins University School of Medicine, Baltimore, MD, briefly comments on the results of a cross-sectional study which used data from the US National Inpatient Sample to investigate risk of severe maternal morbidity in patients with sickle cell disease (SCD) and to compare the adverse pregnancy outcomes in these patients to those seen in patients with prenatal anemia but without SCD. This interview was recorded at the 18th Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT) 2023, held in London, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
